In conclusion, our results point to a consistent association of IL6 and IL6R polymorphisms with COVID-19 severity, putatively due to higher expression of these genes related to CC genotypes and their pro-inflammatory consequences, corroborating previous meta-analysis studies correlating them with mortality rates worldwide and their role in pneumonia and immunobiological therapeutic protocols involving IL-6 pathways. This evidence concerns the gene IL6R and COVID-19.